Evolving Past Alzheimer's podcast

Why I'm excited about Aducanumab (Aduhelm)!

0:00
11:58
Rewind 15 seconds
Fast Forward 15 seconds

Dr. Nate Bergman quickly summarizes the story up the FDA's recent "accelerated approval" of Biogen's - Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval...and it's probably not what you think! A quick, but useful listen.

 

In this episode we talk about…

  • The terms of the approval of the drug
  • What Aducanumab was able to accomplish in Alzheimer's patients
  • The circumstances that led to Aducanumab being approved
  • Some of the problems that arise with Aducanumab
  • Why I am excited about Aducanumab

More episodes from "Evolving Past Alzheimer's"